CRCatherine J. Rees

Catherine J. Rees

*This is an algorithmically generated author record based on publicly available information.

Catherine J. Rees has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transnasal Balloon Dilation of the Esophagus

    by Catherine J. Rees, Taylor Fordham, Peter C. Belafsky

    The introduction of transnasal esophagoscopy (TNE) has expanded the otolaryngologist's ability to evaluate esophageal disease in the office setting.1-3 These endoscopes have also facilitated the development of novel transnasal therapeutic procedures. Some of the procedures currently being performed through ultrathin transnasal endoscopes include placement of nasoenteric feeding tubes, esophageal botulinum toxin injections, and office tracheoesophageal puncture.4-7


    • 1 December 2007
      • Vol. 86  (12) , 732

    Upper esophageal web.

    by Catherine J Rees, Peter C Belafsky

  • In-office transnasal esophagoscope-guided botulinum toxin injection of the lower esophageal sphincter

    by Catherine J Rees

    Thin caliber transnasal esophagoscopes allow for a rapidly expanding array of office-based esophageal procedures, including botulinum toxin injections, in unsedated patients. While botulinum toxin has been used in the esophagus and lower esophageal sphincter for many years, there is no current description of performing this procedure in an unsedated patient using transnasal esophagoscopy. Indications include achalasia, hypertensive lower esophageal sphincter, distal esophageal spasm, nutcracker esophagus and obstructing muscular rings. There is a paucity of data in the literature pertaining to spastic esophageal motility disorders and muscular rings. Randomized controlled trials of achalasia treatments suggest that botulinum toxin injections should be reserved for patients who are poor surgical candidates and/or have failed pneumatic dilation. In-office transnasal esophagoscopy-guided lower esophageal sphincter botulinum toxin injection has not been described in the literature. Indications include esophageal spasm, muscular rings and achalasia, with recent data suggesting that botulinum toxin should not be an initial therapy for most patients with achalasia.


  • In-office unsedated transnasal balloon dilation of the esophagus and trachea

    by Catherine J Rees

    Since the advent of ultrathin flexible endoscopes with working channels office-based esophagoscopy and tracheobronchoscopy have been undertaken frequently by otolaryngologists. As a natural extension of these diagnostic procedures, more office-based esophageal and tracheal therapeutic procedures are being undertaken. Esophageal and tracheal balloon dilation can be performed in the unsedated patient using a transnasal approach. These transnasal techniques have not been described in the recent literature. Esophageal balloon dilation is a well-accepted technique for gastrointestinal endoscopists, and recent literature has focused on indications (such as cricopharyngeal dysfunction) and the development of removable stents for prevention of restenosis. Pulmonary balloon dilation is likewise well accepted, with recent literature focusing on the timing of intervention and the incidence of tracheobronchial laceration. Office-based esophageal and tracheal balloon dilations in unsedated patients are newly described techniques made possible with thin-caliber transnasal endoscopes.


    • 1 June 2007
      • Vol. 86  (6) , 336

    Distal esophageal spasm.

    by Catherine J Rees, Peter C Belafsky

    • 1 April 2007
      • Vol. 86  (4) , 210

    Gastric carcinoma.

    by Catherine J Rees, Peter C Belafsky